Healthcare
3i-backed Ponroy buys Densmore
Second bolt-on the group has made since 3i's initial buyout of the business in 2016
CapVest targets €1bn for fourth fund
Vehicle is a significant increase on CapVest Equity Partners III, which closed on €482m
BDC to exit dental imaging company Acteon
Acteon was the second investment in France made by Bridgepoint Development Capital II
CareVentures holds first close on €60m
Vehicle was registered in Luxembourg as CareVentures Fund II SCSP in April this year
GED's Vitro bolts on Cytognos
Following the acquisition, the combined group expects to reach sales of around €25m in 2018
Balderton leads $10m series-A for HealX
Drug repurposing company will more than double its headcount and invest in product development
CapDecisif holds first close for CapDecisif 4
VC is aiming to exceed its €50m target but will not surpass the €70m assigned hard-cap
ADV leads $8m round for Snap40
UK-based growth and venture capital firm MMC Ventures is also participating in the funding round
Panakes, Invitalia in €3m series-A for Aileens Pharma
Panakes principal Barbara Castellano and Invitalia’s Svetlana Vashkel will join the board
Sofinnova leads €4m seed round for Enthera
JDRF T1D Fund, managed by the Juvenile Diabetes Research Foundation, also takes part in the round
Compass completes portfolio acquisition from Bridgepoint
Deal sees Compass acquiring Bridgepoint's remaining interests in Rodenstock and Infinitas
Capital Croissance exits BioBank
Following the deal, Capital Croissance will reinvest in the company by acquiring a minority holding
SHS V holds first close on €90m
Vehicle was launched in March 2018 with a target of €150m, a 20% increase on SHS IV
The Carlyle Group buys LPG Systems
Europe and Asia-focused funds deployed to back France-based LPG, in view of Asian expansion
Abris acquires ITP
Company plans on expanding into the aesthetic medicine markets in China and the US
VC firms in $25m round for Polares Medical
Earlybird Venture Capital, Wellington Partners and Endeavour Vision also take part
VC firms sell Biosensia
Vendors include Act Venture Capital, Atlantic Bridge, Street Capital and Seroba Life Sciences
BPI France launches InnoBio 2
BPI France and France-based corporate Sanofi have already made commitments to the vehicle
Tesi co-leads €5m funding round for Oura
US-based Bold Capital Partners co-leads the deal and will introduce US industry specialists to the board
Forbion holds first close above target at €270m
Fund officially launched in May 2018 and Forbion expects to hold a final close in Autumn 2018
CVC in take-private deal for Hygeia
CVC Capital Partners is structuring the deal through special purpose vehicle Hellenic Healthcare
Abingworth closes 12th fund on $315m
ABV VII will follow the same strategy as its predecessor, investing in early- and late-stage deals
Andera et al. back Dynacure in €47m round
Investors support the biotech business in advancing its lead programme into clinical development
Auriga Partners leads €7m series-A for Nextbiotix
New funding will be used to support efforts in bringing new medicine to patients